Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Lung/Thoracic Oncology

Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non–small cell lung cancer and melanoma brain metastases

Cancer | Sep 18, 2020 Lung/Thoracic Oncology

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 vs next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients

BMC Cancer | Sep 18, 2020 Lung/Thoracic Oncology

Metabolic syndrome and risk of lung cancer: An analysis of Korean National Health Insurance Corporation database

Journal of Clinical Endocrinology and Metabolism | Sep 16, 2020 Lung/Thoracic Oncology

Pembrolizumab plus chemotherapy vs chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials

Cancer | Sep 16, 2020 Lung/Thoracic Oncology

Re-biopsy after first line treatment in advanced NSCLC can reveal changes in PD-L1 expression

Lung Cancer | Sep 16, 2020 Lung/Thoracic Oncology

Prognostic effect of incongruous lymph node status in early-stage non-small cell lung cancer

European Journal of Surgical Oncology | Sep 16, 2020 Lung/Thoracic Oncology

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer

Lung Cancer | Sep 12, 2020 Lung/Thoracic Oncology

Combination of brachytherapy with iodine-125 seeds and systemic chemotherapy vs systemic chemotherapy alone for synchronous extracranial oligometastatic non-small cell lung cancer

Cancer Management and Research | Sep 12, 2020 Lung/Thoracic Oncology

Conditional relative survival and competing mortality in patients who underwent surgery for lung cancer: A nationwide cohort study

International Journal of Cancer | Sep 11, 2020 Lung/Thoracic Oncology

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179

Cancer | Sep 11, 2020 Lung/Thoracic Oncology

« Prev 1 … 41 42 43 44 45 … 149 Next »

Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non–small cell lung cancer and melanoma brain metastases

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 vs next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients

Metabolic syndrome and risk of lung cancer: An analysis of Korean National Health Insurance Corporation database

Pembrolizumab plus chemotherapy vs chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials

Re-biopsy after first line treatment in advanced NSCLC can reveal changes in PD-L1 expression

Prognostic effect of incongruous lymph node status in early-stage non-small cell lung cancer

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer

Combination of brachytherapy with iodine-125 seeds and systemic chemotherapy vs systemic chemotherapy alone for synchronous extracranial oligometastatic non-small cell lung cancer

Conditional relative survival and competing mortality in patients who underwent surgery for lung cancer: A nationwide cohort study

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non–small cell lung cancer and melanoma brain metastases

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 vs next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients

Metabolic syndrome and risk of lung cancer: An analysis of Korean National Health Insurance Corporation database

Pembrolizumab plus chemotherapy vs chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials

Re-biopsy after first line treatment in advanced NSCLC can reveal changes in PD-L1 expression

Prognostic effect of incongruous lymph node status in early-stage non-small cell lung cancer

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer

Combination of brachytherapy with iodine-125 seeds and systemic chemotherapy vs systemic chemotherapy alone for synchronous extracranial oligometastatic non-small cell lung cancer

Conditional relative survival and competing mortality in patients who underwent surgery for lung cancer: A nationwide cohort study

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic